Electrospray ionization LC-MS/MS validated method to quantify griseofulvin in human plasma and its application to bioequivalence study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 850, Issue 1-2, 2007, Pages 318-326

  Mistri, Hiren N ^a,b   Jangid, Arvind G ^b   Sanyal, Mallika ^c   Shrivastav, Pranav ^a  

^a GUJARAT UNIVERSITY   (India)

^b Accutest Research Laboratories I Pvt Ltd   (India)

^c ST XAVIER S COLLEGE   (India)

Author keywords

Griseofulvin; Human plasma; LC MS MS; Pilot bioequivalence; Solid phase extraction

Indexed keywords

ACETONITRILE; ELECTROSPRAY IONIZATION; FORMIC ACID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMAS;

GRISEOFULVIN; HUMAN PLASMA; PILOT BIOEQUIVALENCE; SOLID PHASE EXTRACTION;

ANTIBIOTICS;

ACETONITRILE; GRISEOFULVIN; PROPRANOLOL;

ARTICLE; BIOEQUIVALENCE; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY;

ANTIFUNGAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GRISEOFULVIN; HUMANS; PILOT PROJECTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THERAPEUTIC EQUIVALENCY;

EID: 34247324742     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.12.003     Document Type: Article

References (24)

1. Develoux M. Ann. Dermatol. Venereol. 128 (2001) 317
2. Oxford A.E., Raistrick H., and Simonart P. Biochem. J. 33 (1939) 240
3. Sorrentino L., Capasso F., and Di Rosa M. Agents Action 7 (1977) 157
4. Dollery C. Griseofulvin in Therapeutics Drugs (1991), Churchill Livingstone, Edinburgh p. G66
5. Becker L.E. Dermatol. Clinics 2 (1984) 115
6. Garceau Y., Brisson J., Davis I., DeAngelis R.L., and Hasegawa J. J. Pharm. Sci. 69 (1980) 561
7. Fischer L.J., and Riegelman S. J. Chromatogr. 21 (1966) 268
8. Cole R.J., Kirksey J.W., and Holaday C.E. Appl. Microbiol. 19 (1970) 106
9. Zia H., Proveaux W.J., O'Donnell J.P., and Ma J.K. J. Chromatogr. 181 (1980) 77
10. Meyer M.C., and Raghow G. J. Pharm. Sci. 68 (1979) 1127
11. Nation R.L., Peng G.W., Smith V., and Chiou W.L. J. Pharm. Sci. 67 (1978) 805
12. Hackett L.P., and Dusci L.J. J. Chromatogr. 155 (1978) 206
13. Kamimura H., Omi Y., Shiobara Y., Tamaki N., and Katogi Y. J. Chromatogr. 163 (1979) 271
14. Schwarz H.J., Waldman B.A., and Madrid V. J. Pharm. Sci. 65 (1976) 370
15. Suenaga Y., and Yasukawa N. Jpn. J. Antibiot. 28 (1975) 665
16. Martin A., Jurado M., Rodriguez M., Nunez F., and Cordoba J.J. J. Food Protection 67 (2004) 2234
17. Petit K.E., Mondeguer F., Roquebert M.F., Biard J.F., and Pouchus Y.F. J. Microbiol. Methods 58 (2004) 59
18. Rundberget T., and Wilkins A.L. J. Chromatogr. A 964 (2002) 189
19. Vudathala G.K., and Rogers J.A. J. Pharm. Sci. 81 (1992) 1166
20. Venkataram S., and Rogers J.A. J. Pharm. Sci. 77 (1988) 933
21. Tur K.M., Ch'ng H.-S., and Baie S. Int. J. Pharmaceutics 148 (1997) 63
22. Mensch J., Noppe M., Adriaensen J., Melis A., Mackie C., Augustijns P., and Brewster M.E. J. Chromatogr. B (2006)
23. Guidance for Industry: Bioanalytical Method validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001.
24. FDA Guidance for Industry: Bioavailability Studies for Orally Administered Drug- Products-General Considerations, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), 2000.